Antagonism of cardiac arrhythmias by dl-1-(2-acetyl-4-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane (M & B 17,803A), a new beta adrenoreceptor blocking agent.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000813:Anilides / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac / Q000517:prevention & control; D001794:Blood Pressure / Q000187:drug effects; D002301:Cardiac Glycosides / Q000037:antagonists & inhibitors / Q000633:toxicity; D004285:Dogs; D004837:Epinephrine / Q000037:antagonists & inhibitors; D004983:Ethanolamines / Q000494:pharmacology*; D005260:Female; D006221:Halothane; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D010042:Ouabain; D010647:Phenyl Ethers / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D013610:Tachycardia / Q000139:chemically induced / Q000517:prevention & control; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; D000813:Anilides; D000889:Anti-Arrhythmia Agents; D002301:Cardiac Glycosides; D004983:Ethanolamines; D010647:Phenyl Ethers; D011437:Propylamines; D010042:Ouabain; D006221:Halothane; D004837:Epinephrine